Adeshwar Meditex Share Price
Sector: Medical Equipment & Supplies
18.00 0.00 (0.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
0.00
Today’s High
0.00
52 Week Low
15.00
52 Week High
27.50
Key Metrics
- Market Cap (In Cr) 25.98
- Beta 1.97
- Div. Yield (%) 0
- P/B 0.7
- TTM P/E 10.77
- Sector P/E 40.98
- D/E 0
- Open Price 0
- Prev Close 18
Adeshwar Meditex Analysis
Price Analysis
-
1 Week-1.37%
-
3 Months7.14%
-
6 Month-25%
-
YTD-30.77%
-
1 Year-33.33%
Risk Meter
- 136% Low risk
- 136% Moderate risk
- 136% Balanced Risk
- 136% High risk
- 136% Extreme risk
Adeshwar Meditex Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 83.71
- Selling/ General/ Admin Expenses Total
- 2.2
- Depreciation/ Amortization
- 0.5
- Other Operating Expenses Total
- 2.73
- Total Operating Expense
- 79.84
- Operating Income
- 3.87
- Net Income Before Taxes
- 2.79
- Net Income
- 2.07
- Diluted Normalized EPS
- 1.43
- Period
- 2025
- Total Assets
- 72.2
- Total Liabilities
- 35.24
- Total Equity
- 36.96
- Tangible Book Valueper Share Common Eq
- 25.61
- Period
- 2025
- Cashfrom Operating Activities
- 3.8
- Cashfrom Investing Activities
- 0.51
- Cashfrom Financing Activities
- -2.66
- Net Changein Cash
- 1.65
- Period
- 2024
- Total Revenue
- 79.85
- Selling/ General/ Admin Expenses Total
- 1.76
- Depreciation/ Amortization
- 0.6
- Other Operating Expenses Total
- 3.1
- Total Operating Expense
- 75.27
- Operating Income
- 4.58
- Net Income Before Taxes
- 2.79
- Net Income
- 2.01
- Diluted Normalized EPS
- 1.39
- Period
- 2024
- Total Assets
- 64.04
- Total Liabilities
- 29.13
- Total Equity
- 34.91
- Tangible Book Valueper Share Common Eq
- 24.19
- Period
- 2024
- Cashfrom Operating Activities
- 3.84
- Cashfrom Investing Activities
- -0.22
- Cashfrom Financing Activities
- -4.36
- Net Changein Cash
- -0.75
- Period
- 2023
- Total Revenue
- 82.36
- Selling/ General/ Admin Expenses Total
- 2.11
- Depreciation/ Amortization
- 0.53
- Other Operating Expenses Total
- 5.57
- Total Operating Expense
- 77.71
- Operating Income
- 4.65
- Net Income Before Taxes
- 2.9
- Net Income
- 2.07
- Diluted Normalized EPS
- 1.44
- Period
- 2023
- Total Assets
- 67
- Total Liabilities
- 34.09
- Total Equity
- 32.91
- Tangible Book Valueper Share Common Eq
- 22.81
- Period
- 2023
- Cashfrom Operating Activities
- 5.93
- Cashfrom Investing Activities
- -1.16
- Cashfrom Financing Activities
- -4.78
- Net Changein Cash
- -0.02
- Period
- 2022
- Total Revenue
- 64.76
- Selling/ General/ Admin Expenses Total
- 2.15
- Depreciation/ Amortization
- 0.38
- Other Operating Expenses Total
- 4.34
- Total Operating Expense
- 61.77
- Operating Income
- 2.99
- Net Income Before Taxes
- 1.19
- Net Income
- 0.79
- Diluted Normalized EPS
- 0.55
- Period
- 2022
- Total Assets
- 72.57
- Total Liabilities
- 41.62
- Total Equity
- 30.95
- Tangible Book Valueper Share Common Eq
- 21.45
- Period
- 2022
- Cashfrom Operating Activities
- -2.44
- Cashfrom Investing Activities
- -1.16
- Cashfrom Financing Activities
- 4.44
- Net Changein Cash
- 0.85
- Period
- 2021
- Total Revenue
- 65.97
- Selling/ General/ Admin Expenses Total
- 2.42
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 4.29
- Total Operating Expense
- 61.71
- Operating Income
- 4.26
- Net Income Before Taxes
- 2.34
- Net Income
- 1.68
- Diluted Normalized EPS
- 1.59
- Period
- 2021
- Total Assets
- 62.31
- Total Liabilities
- 41.72
- Total Equity
- 20.58
- Tangible Book Valueper Share Common Eq
- 19.53
- Period
- 2021
- Cashfrom Operating Activities
- 3.15
- Cashfrom Investing Activities
- -0.71
- Cashfrom Financing Activities
- -3.11
- Net Changein Cash
- -0.66
- Period
- 2020
- Total Revenue
- 56.12
- Selling/ General/ Admin Expenses Total
- 2.38
- Depreciation/ Amortization
- 0.34
- Other Operating Expenses Total
- 4.02
- Total Operating Expense
- 51.06
- Operating Income
- 5.05
- Net Income Before Taxes
- 2.81
- Net Income
- 2.01
- Diluted Normalized EPS
- 1.4
- Period
- 2020
- Total Assets
- 54.81
- Total Liabilities
- 35.99
- Total Equity
- 18.81
- Tangible Book Valueper Share Common Eq
- 13.02
- Period
- 2020
- Cashfrom Operating Activities
- 0.54
- Cashfrom Investing Activities
- -0.05
- Cashfrom Financing Activities
- -0.15
- Net Changein Cash
- 0.34
- Period
- 2019
- Total Revenue
- 52.92
- Selling/ General/ Admin Expenses Total
- 2.26
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 3.1
- Total Operating Expense
- 49.39
- Operating Income
- 3.53
- Net Income Before Taxes
- 3.12
- Net Income
- 2.25
- Diluted Normalized EPS
- 1.56
- Period
- 2019
- Total Assets
- 43.87
- Total Liabilities
- 28.07
- Total Equity
- 15.8
- Tangible Book Valueper Share Common Eq
- 10.93
- Period
- 2019
- Cashfrom Operating Activities
- -5.87
- Cashfrom Investing Activities
- -0.3
- Cashfrom Financing Activities
- 6.22
- Net Changein Cash
- 0.05
- Period
- 2025-03-31
- Total Revenue
- 37.45
- Selling/ General/ Admin Expenses Total
- 1.44
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.28
- Total Operating Expense
- 35.49
- Operating Income
- 1.95
- Net Income Before Taxes
- 1.82
- Net Income
- 1.34
- Diluted Normalized EPS
- 0.93
- Period
- 2025-03-31
- Total Assets
- 72.2
- Total Liabilities
- 35.24
- Total Equity
- 36.96
- Tangible Book Valueper Share Common Eq
- 25.61
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 3.8
- Cashfrom Investing Activities
- 0.51
- Cashfrom Financing Activities
- -2.66
- Net Changein Cash
- 1.65
- Period
- 2024-09-30
- Total Revenue
- 40.9
- Selling/ General/ Admin Expenses Total
- 0.78
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 1.3
- Total Operating Expense
- 39.14
- Operating Income
- 1.75
- Net Income Before Taxes
- 1.25
- Net Income
- 0.9
- Diluted Normalized EPS
- 0.63
- Period
- 2024-09-30
- Total Assets
- 64.57
- Total Liabilities
- 28.75
- Total Equity
- 35.81
- Tangible Book Valueper Share Common Eq
- 24.82
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 5.3
- Cashfrom Investing Activities
- 0.49
- Cashfrom Financing Activities
- -2.49
- Net Changein Cash
- 3.29
- Period
- 2024-03-31
- Total Revenue
- 33.59
- Selling/ General/ Admin Expenses Total
- 1.01
- Depreciation/ Amortization
- 0.31
- Other Operating Expenses Total
- 0.65
- Total Operating Expense
- 30.92
- Operating Income
- 2.66
- Net Income Before Taxes
- 1.81
- Net Income
- 1.29
- Diluted Normalized EPS
- 0.89
- Period
- 2024-03-31
- Total Assets
- 64.04
- Total Liabilities
- 29.13
- Total Equity
- 34.91
- Tangible Book Valueper Share Common Eq
- 24.19
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 3.84
- Cashfrom Investing Activities
- -0.22
- Cashfrom Financing Activities
- -4.36
- Net Changein Cash
- -0.75
- Period
- 2023-09-30
- Total Revenue
- 46.26
- Selling/ General/ Admin Expenses Total
- 0.75
- Depreciation/ Amortization
- 0.29
- Other Operating Expenses Total
- 2.45
- Total Operating Expense
- 44.35
- Operating Income
- 1.91
- Net Income Before Taxes
- 0.97
- Net Income
- 0.72
- Diluted Normalized EPS
- 0.5
- Period
- 2023-09-30
- Total Assets
- 71.43
- Total Liabilities
- 37.79
- Total Equity
- 33.64
- Tangible Book Valueper Share Common Eq
- 23.31
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 4.91
- Cashfrom Investing Activities
- -0.5
- Cashfrom Financing Activities
- -3.84
- Net Changein Cash
- 0.57
- Period
- 2023-03-31
- Total Revenue
- 36.3
- Selling/ General/ Admin Expenses Total
- 1.11
- Depreciation/ Amortization
- 0.27
- Other Operating Expenses Total
- 2.5
- Total Operating Expense
- 34.11
- Operating Income
- 2.19
- Net Income Before Taxes
- 1.4
- Net Income
- 0.99
- Diluted Normalized EPS
- 0.69
- Period
- 2023-03-31
- Total Assets
- 67
- Total Liabilities
- 34.09
- Total Equity
- 32.91
- Tangible Book Valueper Share Common Eq
- 22.81
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 5.93
- Cashfrom Investing Activities
- -1.16
- Cashfrom Financing Activities
- -4.78
- Net Changein Cash
- -0.02
- Period
- 2022-09-30
- Total Revenue
- 46.06
- Selling/ General/ Admin Expenses Total
- 0.99
- Depreciation/ Amortization
- 0.26
- Other Operating Expenses Total
- 3.08
- Total Operating Expense
- 43.59
- Operating Income
- 2.46
- Net Income Before Taxes
- 1.51
- Net Income
- 1.09
- Diluted Normalized EPS
- 0.75
- Period
- 2022-09-30
- Total Assets
- 68.96
- Total Liabilities
- 36.92
- Total Equity
- 32.04
- Tangible Book Valueper Share Common Eq
- 22.2
- Period
- 2022-09-30
- Cashfrom Operating Activities
- 1.58
- Cashfrom Investing Activities
- -0.54
- Cashfrom Financing Activities
- -1.13
- Net Changein Cash
- -0.09
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Adeshwar Meditex Technical
Moving Average
SMA
- 5 Day17.49
- 10 Day17.24
- 20 Day17.61
- 50 Day21.09
- 100 Day0
- 300 Day0
Adeshwar Meditex Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Centenial Surgical Suture
- 147.1
- -1.55
- -1.04
- 169.5
- 82.15
- 53.66
- Gkb Ophthalmics
- 74.97
- -1.13
- -1.48
- 131.75
- 59
- 37.84
- Shree Pacetronix
- 74.4
- 0.39
- 0.53
- 245
- 61.11
- 26.46
- Adeshwar Meditex
- 18
- 0
- 0
- 27.5
- 15
- 25.98
- Transpact Enterprises
- 293.8
- 0
- 0
- 350
- 130.6
- 11.15
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Centenial Surgical Suture
- -
- 1.76
- 1.4
- 0.9
- Gkb Ophthalmics
- -
- 0.74
- -3.18
- -2.4
- Shree Pacetronix
- 35.58
- 1.93
- 18.46
- 10.81
- Adeshwar Meditex
- 12.59
- 0.7
- 5.85
- 2.29
- Transpact Enterprises
- 1262.46
- 25.16
- -14.13
- -67.62
Adeshwar Meditex Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results
- 24-Feb-25
- Others
- 13-Nov-24
- Half Yearly Results
- 26-Aug-24
- A.G.M.
- 22-May-24
- Audited Results
- 03-Nov-23
- Half Yearly Results
- 25-May-23
- Audited Results
- 26-Apr-23
- Others
- 04-Nov-22
- Half Yearly Results & Others
- 13-May-22
- Audited & Half Yearly Results
- Meeting Date
- Announced on
- Purpose
- 25-Sept-24
- 26-Aug-24
- AGM
- 26-Sept-23
- 28-Aug-23
- AGM
- 26-May-23
- 26-Apr-23
- EGM



